128 related articles for article (PubMed ID: 33086204)
1. Differentiating cancer types using a urine test for volatile organic compounds.
Bannaga AS; Kvasnik F; Persaud K; Arasaradnam RP
J Breath Res; 2020 Dec; 15(1):017102. PubMed ID: 33086204
[TBL] [Abstract][Full Text] [Related]
2. Urinary volatile compounds as biomarkers for lung cancer.
Hanai Y; Shimono K; Matsumura K; Vachani A; Albelda S; Yamazaki K; Beauchamp GK; Oka H
Biosci Biotechnol Biochem; 2012; 76(4):679-84. PubMed ID: 22484930
[TBL] [Abstract][Full Text] [Related]
3. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
[TBL] [Abstract][Full Text] [Related]
4. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
[TBL] [Abstract][Full Text] [Related]
5. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
Silva CL; Passos M; Câmara JS
Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma.
Bannaga AS; Tyagi H; Daulton E; Covington JA; Arasaradnam RP
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922256
[TBL] [Abstract][Full Text] [Related]
7. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
[TBL] [Abstract][Full Text] [Related]
8. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of volatile organic compounds with a wide range of polarities in urine by headspace solid-phase microextraction coupled to gas chromatography/mass spectrometry.
Song HN; Kim CH; Lee WY; Cho SH
Rapid Commun Mass Spectrom; 2017 Apr; 31(7):613-622. PubMed ID: 28085216
[TBL] [Abstract][Full Text] [Related]
10. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
Zhang S; Raftery D
Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
[TBL] [Abstract][Full Text] [Related]
11. Development of headspace SPME method for analysis of volatile organic compounds present in human biological specimens.
Kusano M; Mendez E; Furton KG
Anal Bioanal Chem; 2011 Jun; 400(7):1817-26. PubMed ID: 21598081
[TBL] [Abstract][Full Text] [Related]
12. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
13. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
[TBL] [Abstract][Full Text] [Related]
14. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
[TBL] [Abstract][Full Text] [Related]
15. Urinary volatile organic compounds in overweight compared to normal-weight children: results from the Italian I.Family cohort.
Cozzolino R; De Giulio B; Marena P; Martignetti A; Günther K; Lauria F; Russo P; Stocchero M; Siani A
Sci Rep; 2017 Nov; 7(1):15636. PubMed ID: 29142292
[TBL] [Abstract][Full Text] [Related]
16. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
[TBL] [Abstract][Full Text] [Related]
17. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
18. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression: a first approach for breast cancer.
Silva CL; Perestrelo R; Silva P; Tomás H; Câmara JS
Metabolomics; 2019 Apr; 15(4):64. PubMed ID: 30997581
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of an SPME fiber based on ZnO@GA nanorods coated onto fused silica as a highly efficient absorbent for the analysis of cancer VOCs in water and urine.
Naseri N; Kharrazi S; Abdi K; Alizadeh R
Anal Chim Acta; 2021 Oct; 1183():338983. PubMed ID: 34627504
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive detection of colorectal cancer by analysis of exhaled breath.
Wang C; Ke C; Wang X; Chi C; Guo L; Luo S; Guo Z; Xu G; Zhang F; Li E
Anal Bioanal Chem; 2014 Jul; 406(19):4757-63. PubMed ID: 24820062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
